Published on
June 7, 2023
- 05:21 GMT
SimcereZaiming showcases latest R&D progressed on its debut at ASCO， as 6 studies regarding 3 products published at ASCO
Simcere Zaiming, an innovative oncology-focused biopharma and a subsidiary of Simcere Pharmaceutical Group, exhibited a booth at ASCO for the first time. BOSTON, MASSACHUSETTS, THE UNITED STATES, June 6, 2023 /EINPresswire.com/ -- The annual meeting of …
Distribution channels:
Banking, Finance & Investment Industry, Companies
...
